Aligos Therapeutics Inc. (ALGS)
23.69
-0.25 (-1.06%)
At close: Jan 30, 2025, 3:59 PM
23.80
0.44%
After-hours Jan 30, 2025, 05:12 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -87.68M | -96.05M | -128.33M | -108.54M | -52.26M | -13.93M |
| Depreciation & Amortization | 3.07M | 3.67M | 3.78M | 3.33M | 2.30M | 1.29M |
| Stock-Based Compensation | 12.65M | 14.69M | 13.46M | 2.98M | 752.00K | 179.00K |
| Other Working Capital | -7.31M | -3.27M | -4.34M | 16.19M | 3.29M | 1.91M |
| Other Non-Cash Items | 2.49M | -159.00K | 86.00K | 11.39M | -1.23M | 1.64M |
| Deferred Income Tax | n/a | n/a | n/a | 530.00K | n/a | -110.00K |
| Change in Working Capital | -9.53M | -1.55M | -4.65M | 16.06M | 3.67M | 4.88M |
| Operating Cash Flow | -79.00M | -79.39M | -115.66M | -74.26M | -46.77M | -6.05M |
| Capital Expenditures | -19.00K | -943.00K | -892.00K | -2.06M | -2.79M | -2.52M |
| Acquisitions | n/a | 25.35M | -3.91M | -34.82M | -9.58M | n/a |
| Purchase of Investments | -11.00K | -104.27M | -19.09M | -45.28M | -70.42M | -66.77M |
| Sales Maturities Of Investments | 45.01M | 78.92M | 23.00M | 80.10M | 80.00M | n/a |
| Other Investing Acitivies | n/a | -25.35M | 3.91M | 34.82M | 9.58M | -72.84M |
| Investing Cash Flow | 44.98M | -26.29M | 3.02M | 32.76M | 6.79M | -69.29M |
| Debt Repayment | -96.00K | -61.00K | -79.00K | -58.00K | -43.00K | 5.00M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 70.98M | 225.00K | 172.00K | 40.00M | 85.58M | 94.88M |
| Financial Cash Flow | 88.33M | 164.00K | 78.68M | 192.35M | 85.53M | 99.89M |
| Net Cash Flow | 54.31M | -105.52M | -33.96M | 150.84M | 45.56M | 24.55M |
| Free Cash Flow | -79.02M | -80.33M | -116.55M | -76.33M | -49.55M | -8.56M |